1. Home
  2. TELO vs KOSS Comparison

TELO vs KOSS Comparison

Compare TELO & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • KOSS
  • Stock Information
  • Founded
  • TELO 2021
  • KOSS 1953
  • Country
  • TELO United States
  • KOSS United States
  • Employees
  • TELO N/A
  • KOSS N/A
  • Industry
  • TELO
  • KOSS Consumer Electronics/Appliances
  • Sector
  • TELO
  • KOSS Consumer Staples
  • Exchange
  • TELO NYSE
  • KOSS Nasdaq
  • Market Cap
  • TELO 58.6M
  • KOSS 59.3M
  • IPO Year
  • TELO 2024
  • KOSS N/A
  • Fundamental
  • Price
  • TELO $1.53
  • KOSS $4.99
  • Analyst Decision
  • TELO
  • KOSS
  • Analyst Count
  • TELO 0
  • KOSS 0
  • Target Price
  • TELO N/A
  • KOSS N/A
  • AVG Volume (30 Days)
  • TELO 408.8K
  • KOSS 93.3K
  • Earning Date
  • TELO 08-12-2025
  • KOSS 05-08-2025
  • Dividend Yield
  • TELO N/A
  • KOSS N/A
  • EPS Growth
  • TELO N/A
  • KOSS N/A
  • EPS
  • TELO N/A
  • KOSS N/A
  • Revenue
  • TELO N/A
  • KOSS $12,433,361.00
  • Revenue This Year
  • TELO N/A
  • KOSS N/A
  • Revenue Next Year
  • TELO N/A
  • KOSS N/A
  • P/E Ratio
  • TELO N/A
  • KOSS N/A
  • Revenue Growth
  • TELO N/A
  • KOSS N/A
  • 52 Week Low
  • TELO $1.52
  • KOSS $4.00
  • 52 Week High
  • TELO $8.40
  • KOSS $18.73
  • Technical
  • Relative Strength Index (RSI)
  • TELO 29.64
  • KOSS 44.47
  • Support Level
  • TELO $1.65
  • KOSS $4.63
  • Resistance Level
  • TELO $1.81
  • KOSS $5.75
  • Average True Range (ATR)
  • TELO 0.17
  • KOSS 0.37
  • MACD
  • TELO -0.01
  • KOSS -0.06
  • Stochastic Oscillator
  • TELO 1.03
  • KOSS 23.53

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: